Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 12Neoplasms 8Prostatic Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Pain 2Multiple Myeloma 2Melanoma 2Hematologic Neoplasms 2Fatigue 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Weight Loss 1Uterine Cervical Neoplasms 1To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT 1Thymus Neoplasms 1Thrombocytopenia 1Symptom Management 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Splenomegaly 1Speech 1Sexual Dysfunction, Physiological 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Synovial 1Rectal Neoplasms 1

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lime 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Sirolimus 1Silymarin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cognitive Dysfunction × Quality of Life × Clear all
NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Completed
267 enrolled
CNS

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡